Author(s): van der Rhee HJ, van Gelderen HH, Polano MK
Abstract Share this page
Abstract In 5 children ranging in age from 8 to 12 years, treatment with Ro 10-9359 for either psoriasis or erythrokeratodermia variabilis for periods of between 11 and 17 months did not cause marked growth retardation and gave excellent therapeutic results.
This article was published in Acta Derm Venereol
and referenced in Journal of Clinical & Experimental Dermatology Research